Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature
- PMID: 2548911
- DOI: 10.1159/000199835
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature
Abstract
We report 1 patient with a necrolytic migratory erythema, a high plasma glucagon concentration and a metastatic pancreatic endocrine tumor who has now been treated effectively for 33 months with the somatostatin analogue octreotide (SMS 201-995) (400 micrograms/day). The results of SMS 201-995 in the treatment of glucagonoma syndrome are reviewed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
